Comparing Operative vs Non Operative Treatment for Pilonidal Disease
1 other identifier
interventional
400
1 country
1
Brief Summary
The goal is to evaluate whether surgical excision of the pilonidal disease is needed after resolution of the initial symptoms when the patient follows regular hair removal regimen such as laser epilation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2022
CompletedFirst Posted
Study publicly available on registry
June 30, 2022
CompletedStudy Start
First participant enrolled
July 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
November 22, 2024
November 1, 2024
4.5 years
June 9, 2022
November 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of participants with recurrent symptoms of pilonidal disease
Up to 1 year
Secondary Outcomes (4)
Number of participants requiring antibiotic treatment
Up to 1 year
Time taken off from school or work due to pilonidal disease
Up to 1 year
Effect on parent's daily activities
Baseline to 1 year
Number of participants requiring additional surgical intervention
Up to 1 year
Study Arms (2)
Regular epilation regimen only
ACTIVE COMPARATORRegular epilation regimen with surgical excision
ACTIVE COMPARATORInterventions
Epilation using laser device
Excision of pilonidal pit with trephine
Eligibility Criteria
You may qualify if:
- Patients at Stanford Healthcare with pilonidal disease.
- Patients over the age of 8yrs.
You may not qualify if:
- Inability to read, write or understand English \*\*\*or Spanish
- Intellectual disability precluding the patient from being able to comprehend or respond to the questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford University School of Medicine
Palo Alto, California, 94304, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Bill Chiu, MD
Stanford University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Surgery
Study Record Dates
First Submitted
June 9, 2022
First Posted
June 30, 2022
Study Start
July 19, 2022
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 1, 2027
Last Updated
November 22, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share